RecruitingNCT06897670

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study


Sponsor

Mayo Clinic

Enrollment

200 participants

Start Date

Mar 26, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional near-infrared spectroscopy (fNIRS). By comparing brain activity across different groups and relating it to symptom severity, this study aims to improve our understanding of how these conditions affect the brain.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using a non-invasive brain imaging technique called fNIRS (functional near-infrared spectroscopy) to measure blood flow patterns in the brain of people with major depression, bipolar disorder, or mild cognitive impairment, and compare them to healthy individuals. By identifying unique brain activity patterns in each condition, researchers hope to improve diagnosis, track treatment responses, and better understand what happens in the brain during mood and memory disorders. **You may be eligible if...** - You are 18 years or older - You have a confirmed clinical diagnosis of major depressive disorder, bipolar disorder, or mild cognitive impairment (MCI) - You have stable enough symptoms to safely participate in the study tasks - You are able to provide written consent and understand the study procedures - Healthy adults without mental health diagnoses are also eligible to participate as controls **You may NOT be eligible if...** - You have an active psychiatric crisis requiring immediate treatment - You have a condition (such as severe skin disorders or excessive hair) that prevents accurate fNIRS measurement on the scalp - You are currently experiencing a severe episode that impairs your ability to complete the study tasks - You have significant cognitive impairment that prevents informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservational assessment using functional near-infrared spectroscopy (fNIRS), a noninvasive, portable brain imaging tool that measures changes in brain blood flow and oxygen levels.

Functional near-infrared spectroscopy (fNIRS) transcutaneously measures changes in oxyhemoglobin in the prefrontal cortex using light detection. It is designed to measure variations in cerebral hemodynamics on a real-time basis by radiating a near light beam, at two wavelengths of 780nm and 850nm of laser, into the cerebral cortex. Participants will undergo a one-time functional near-infrared spectroscopy (fNIRS) procedure to measure cerebral hemodynamic patterns. * Resting-State Measurement: 5-10 min resting-state scans. * Task-Based Measurement: Participants will be shown an instruction video. Participants will complete a Verbal Fluency Task (VFT) during the fNIRS scan (15-20 min). * During the fNIRS scan, optional basic vital signs will be measured using respiratory belts, photoplethysmography (PPG), and electrocardiogram (ECG). * Each participant will complete 3 sets of resting-state and task-based measurements. Total estimated time for fNIRS assessment: 45-60 min.


Locations(1)

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06897670


Related Trials